The frequency of EGFR mutations in lung cancer in Caucasian is 17%1; in American lung adenocarcinoma populations, the frequency is 23%2; and in Chinese lung adenocarcinoma patients, it is 51%3. This evidence concerns the gene EGFR and lung adenocarcinoma.